Leading in clinical trials
We are home to Australia’s largest collective clinical trials program.
About our clinical trials
For more than 30 years, our clinical trials program has allowed us to put new and cutting-edge treatment into clinical practice. Our highly-engaged research team are always looking to improve the way we deliver care.
We conduct a wide range of commercially-sponsored and investigator-initiated trials, and the opportunity to progress trials from first-in-human to first-in-disease at the one site.
We have strong relationships with universities and medical research institutes in Australia and across the world.
Epilepsy
The Alfred Brain team continues its groundbreaking work in the functional neurosurgery space.
Neuroscience
Study co-ordinator, Jack, standing in the Neuroscience Clinical Trials Unit.
Medical oncology
Principal investigator working closely with trial coordinator nurse to safely deliver a brand new cancer drug to their patient.
Our clinical trials expertise
We have:
- Proven expertise with academic leadership of clinical trial units
- Expertise in the design and delivery of first-in-human trials
- Australia’s first clinical trial pharmacy credentialing program
- Consistent processes and guidelines organisation-wide
- Regional leadership in clinical trials through TrialHub
- Biobanking and registry capabilities
Find out more about all our research areas and research technologies.
Why are clinical trials so important?
We need clinical trials to prove that a new medication, device or treatment is safe and effective for people.
Without clinical trials, new treatments and medicines cannot be approved for use in Australia.
Our clinical trial units
Our researchers are leaders in their fields with decades of experience in conducting Australian and international clinical trials for:
- Anaesthesiology and perioperative medicine
- Cardiology
- Cardiothoracic surgery
- Diagnostic and interventional radiology
- Endocrinology and diabetes
- Gastroenterology and hepatology
- Haematology
- Infectious diseases
- Intensive care
- Medical oncology
- Melanoma and skin cancers
- Mental health and psychiatry
- Neuroscience
- Pharmacy
- Radiation oncology
- Respiratory medicine
- Sexual health
Our leadership
Prof Stephen Jane
As the Director of Research, Stephen Jane is responsible to the Chief Executive for the strategic direction and governance of research at Alfred Health.
Prof Sophia Zoungas
Prof Sophia Zoungas is Deputy Director of Research at Alfred Health and is Head, School of Public Health and Preventive Medicine and Division of Chronic Disease and Ageing, Monash University.
Prof Terence O'Brien
Prof O'Brien is the Program Director Alfred Brain, Deputy Director of Research and Head of Neuroscience Clinical Trials Unit at The Alfred.
Latest news
Hormones lead to cancer treatment breakthrough
Biological differences between men and women can have an impact on the success of melanoma treatment, according to new research co-led by Alfred oncologist Miles Andrews.
Long-term cannabis treatment reduces seizures
A world-first trial of medical cannabis-based treatments for drug resistant epilepsy has shown that prolonged use in adults significantly reduced the frequency of seizures.
Home-based tests boost fight against HIV
Home-based tests designed to rapidly detect the presence of HIV could prove vital in the early diagnosis of the virus among the most vulnerable cohort, new research has revealed.